Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240). - Penson, Richard T; Huang, Helen Q; Wenzel, Lari B; Monk, Bradley J; Stockman, Sharon; Long 3rd, Harry J; Ramondetta, Lois M; Landrum, Lisa M; Oaknin, Ana; Reid, Thomas J A; Leitao, Mario M; Method, Michael; et al. (Lancet Oncology, 2015)